Clearmind Medicine Investor Relations Material
Latest events
Q2 2025
11 Jun, 2025
Q1 2025
12 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Clearmind Medicine Inc
Access all reports
Clearmind Medicine Inc is a Canada-based biotechnology company focused on the research and development of psychedelic-derived therapeutics for the treatment of mental health conditions. The company is developing proprietary compounds aimed at addressing issues such as alcohol use disorder, depression, and anxiety. Clearmind’s approach combines psychedelic science with pharmaceutical development to create regulated treatment options. The company is headquartered in Vancouver, British Columbia, and its shares are listed on the CSE.
Key slides for Clearmind Medicine Inc
Corporate Presentation
Clearmind Medicine Inc
Corporate Presentation
Clearmind Medicine Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CMND
Country
🇺🇸 United States